greeksoup/ stock research
Stock research / United States / LLY / Documents

Eli Lilly & Co. documents

Eli Lilly (LLY) annual report: the 10-K filed 12 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 20 March 2026; latest 10-Q filed 29 October 2026 for the quarter ended 30 September 2026. Each links to the document on EDGAR, with 4 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
29 October 2026Results press release, exhibit 99 to the 8-K filed 29 October 2026The releaseEDGAR folder
5 August 2026Results press release, exhibit 99 to the 8-K filed 5 August 2026The releaseEDGAR folder
30 April 2026Results press release, exhibit 99 to the 8-K filed 30 April 2026The releaseEDGAR folder
4 February 2026Results press release, exhibit 99 to the 8-K filed 4 February 2026The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
12 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
29 October 202610-Q, period ended 30 September 2026The documentEDGAR folder
5 August 202610-Q, period ended 30 June 2026The documentEDGAR folder
30 April 202610-Q, period ended 31 March 2026The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
20 March 2026DEF 14A, period ended 20 March 2026The documentEDGAR folder

Employee plan reports

FiledDocumentOpenWhere
23 June 202611-K, period ended 31 December 2025The documentEDGAR folder